van ZantenARHHofmanZHeylandDK. Consequences of the REDOXS and METAPLUS trials: the end of an era of glutamine and antioxidant supplementation for critically ill patients?JPEN J Parenter Enteral Nutr.2015;39(8):890-892.
2.
HeylandDMuscedereJWischmeyerPE; Canadian Critical Care Trials Group. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368(16):1489-1497.
3.
HeylandDWischmeyerPEDayAG; Canadian Clinical Care Trials Group. Glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;369(5):484-485.
4.
van ZantenARSztarkFKaisersUX. High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA. 2014;312(5):514-524.
5.
van ZantenARHofmanZ.Standard vs enriched high protein enteral nutrition in the ICU—reply. JAMA. 2014;312(21):2288-2289.
6.
van ZantenAR. Glutamine and antioxidants: status of their use in critical illness. Curr Opin Clin Nutr Metab Care. 2015;18(2):179-186.
7.
van den BergheG. Low glutamine levels during critical illness—adaptive or maladaptive?N Engl J Med. 2013;368(16):1549-1550.
